Biora Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update
07 nov. 2022 16h15 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will report third quarter...
Biora Therapeutics Announces $9.75 Million Direct Offering
07 nov. 2022 08h06 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into a...
Biora Therapeutics Announces Sale of Cell-Free DNA Patent Rights
27 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it has completed a one-time asset...
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
25 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today presented detailed results from its PM-602...
Biora Therapeutics Shares Five Posters Presented at American College of Gastroenterology Annual Scientific Meeting 2022
24 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the five posters presented at the...
Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
19 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a poster presented at the Parenteral Drug...
Biora Therapeutics to Participate in 12th Annual Partnership Opportunities in Drug Delivery Conference
10 oct. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, announced today that the company will participate in the...
Biora Therapeutics Announces Issuance of Key Patent for Oral Delivery of GLP-1 Receptor Agonists
13 sept. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, announced today that the United States Patent and...
Biora Therapeutics Appoints Dr. Bruce Sands as Chair of its Clinical Advisory Board
07 sept. 2022 09h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, announced today the appointment of Dr. Bruce Sands as...
Biora Therapeutics to Participate in Upcoming H.C. Wainwright Investment Conference
06 sept. 2022 06h30 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the company’s management team will...